Introduction
Randomised controlled trials are high-quality studies from which decisions regarding treatments are made. 1 While much attention has been paid to standardising randomised trial methods, the collection and reporting of outcomes has been widely neglected. 2 Several systematic reviews have characterised the inconsistency in outcome reporting, for example, 164 different outcomes and 113 different outcome measures have been reported by endometriosis trials. 3 Such *Steering committee listed in Appendix.
heterogeneity results in substantial outcome reporting bias and an inability to synthesise results across studies in systematic reviews. 2 The development and rigorous implementation of core outcome sets would help to address these issues.
Core outcome sets are minimum collections of outcomes with standardised measurement and reporting. 2 They represent a minimum data set of outcomes prioritised by stakeholders, including healthcare professionals, researchers, and patients. 2, 4 Recognising variation in outcome collection and reporting is a serious hindrance to progress in our specialty, over eighty journals have come together to support the Core Outcomes in Women's and Newborn Health (CROWN) initiative. 4, 5 The consortium strongly encourages researchers to develop core outcome sets using appropriate methods, facilitates dissemination, and ensures consistent reporting using such outcome sets across participating journals. 4 This study systematically reviewed and characterised registered, progressing, or completed core outcome sets relevant to women's and newborn health.
Methods
A protocol with explicitly defined objectives, criteria for selection, and approaches to data extraction was developed. The objectives of this systematic review fell outside the scope of the International Prospective Register of Systematic Reviews (PROSPERO) and therefore did not require registration. 6, 7 A systematic literature review was undertaken searching the Core Outcome Measures in Effectiveness Trial (COMET) initiative register and CROWN initiative register from inception to January 2017 (Appendix S1). The COMET initiative register is a database of citations relevant to core outcome set development, including protocols, systematic reviews, and completed core outcome sets. The register is maintained by searches of the Cochrane Methodology Register, MED-LINE, and Scopus. 8, 9 In addition, core outcome developers are encouraged to register prospectively. 8, 9 Two authors independently screened each potentially relevant record based on title and abstract, and then reviewed the full text of selected publications, for example, published protocols, systematic reviews, or core outcome sets. Discrepancies between the authors were resolved through discussion.
Registry entries, protocols, systematic reviews, and core outcome sets relevant to women's or newborn health were included. No language or publication date restrictions were applied. Using a pilot-tested and standardised data extraction form, two authors independently extracted characteristics and data.
For registry entries, characteristics including scope, funder, and registration details were extracted. For published protocols, characteristics, planned quantitative and qualitative methods to identify potential core outcomes, and planned consensus methods to identify core outcomes were extracted. For published systematic reviews, characteristics, methods (search strategy, inclusion criteria, and methodological assessment of included studies), and results (included studies, participants, outcome domains, outcomes, and outcome measures) were extracted. For published core outcome sets, characteristics, quantitative and qualitative methods identifying potential core outcomes, and consensus methods identifying core outcomes were extracted. A reporting guideline for core outcome sets, Core Outcome Set-STAndards for Reporting: the COS-STAR statement, has recently been published. 10 Two authors independently assessed reporting quality of each core outcome set using the statement's 18-item checklist. 10 This study was reported in accordance with the Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA) statement. 1 Descriptive statistics were reported to characterise registry entries, protocols, systematic reviews, and core outcome sets, mapping their characteristics, methods, results, and reporting quality. Where identified, unpublished protocols were sought from the authors.
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Results
The search identified 121 registry records; 35 duplicate records were then excluded, and 86 records were screened by two authors independently. Seventy-seven records were included: 49 core outcome set registry records, seven protocols, 20 systematic reviews, and four core outcome sets ( Figure S1 ).
Registry records
Forty-nine core outcome sets registered with the COMET initiative (n = 44; 89%) and/or CROWN initiative (n = 38; 78%) were identified ( Table 1 ). The majority of registry records were registered in 2015 (n = 22; 45%) or 2016 (n = 16; 33%) ( Figure 1 ). Eight core outcome sets (16%) relevant to benign gynaecology and subfertility, 33 (67%) relevant to pregnancy and childbirth, three (6%) relevant to newborn health, and five (10%) relevant to oncology have been registered (Figure 2 ). Twenty-four of the core outcome sets (50%) received funding for their development from international (n = 1; <1%), national (n = 18; 37%), and regional (n = 4; 8%) bodies (Table 1) .
Published core outcome set protocols
Seven published protocols were identified: endometriosis, termination of pregnancy, pre-eclampsia, diabetes in (Table S1) . [12] [13] [14] [15] [16] [17] [18] The protocols were published in 2015 (n = 1), 2016 (n = 5), or January 2017 (n = 1). Five protocols described core outcome sets funded by international funders, World Health Organization, national funders, including Health Research Board (Ireland), National Institute of Health Research (UK), and Royal College of Obstetricians and Gynaecologists (UK), or regional funders such as Barts Health Charity (London, UK). [12] [13] [14] [15] 17 The scope of the core outcome set was clearly stated in five protocols. [12] [13] [14] [15] [16] [17] All protocols described systematic reviews to identify potential core outcomes. Additionally, three protocols described linked qualitative research methods, including a systematic review of qualitative research and qualitative patient interviews. 12, 14, 16 All protocols intended to identify core outcomes using a modified Delphi method and in addition six protocols intended to organise a consensus development meeting.
Systematic reviews characterising the inconsistency in outcome reporting
Twenty systematic reviews characterising the inconsistency in outcome reporting across a broad range of relevant healthcare conditions were identified (Table S2) . 3, 11, [19] [20] [21] [22] [23] [24] [25] [26] [27] [28] [29] [30] [31] [32] [33] [34] [35] Seventeen systematic reviews (85%) extracted and mapped outcome reporting across included studies, three (15%) mapped predefined outcomes across included studies, and two (10%) investigated outcome reporting bias. 36 The scope was clearly stated in a majority of systematic reviews (n = 12; 60%). The search strategy varied across the included reviews: many (n = 11; 55%) searched multiple bibliographical databases (range: two to seven databases) and applied no date limitations (n = 10; 50%) but a significant minority did not. The search strategy was unclear in two reviews (10%).
In terms of content, a single (5%) review included 25 study protocols, seven reviews (35%) included non-randomised studies (range 28-232), 14 reviews (70%) included randomised trials (range 28-1041), and 10 reviews (50%) included systematic reviews (range 1-174). A minority of reviews (n = 4; 20%) undertook a methodological assessment of included studies. Eleven reviews (55%) mapped both primary and secondary outcomes. The reported variation in outcome reporting was considerable; for example, a review of endometriosis trials identified 164 outcomes and 113 outcome measures and a review of bladder pain syndrome trials identified five outcomes and 19 outcome measures. 3, 19 A minority of reviews (n = 6; 30%) did not explicitly state the number of unique outcomes identified.
Published core outcome sets
Four published core outcome sets were identified: reconstructive breast surgery (11 core outcomes), primary prevention of preterm birth (13 core outcomes), epilepsy in pregnancy (29 core outcomes), and maternity care (48 core outcomes) ( Table 2, Table S3 ).
11, [37] [38] [39] No published core outcome sets clearly defined their scope. All four had made a systematic review of the literature to identify potential core outcomes (Table S3) . Three core outcome sets published their systematic reviews separately. 26, 28, 34, 35, 40 Three reviews clearly described their search strategy, two searched multiple bibliographical databases (range 3-4) and a single review limited their search to the Cochrane Pregnancy and Childbirth Group's Specialised Register. All reviews applied a date restriction and two described the rationale for this: Van 't Hooft et al. 37 included randomised trials published after the first Consolidated Standards of Reporting Trials (CONSORT) statement and Potter et al. 11 included studies from 1980 onwards following the development of modern reconstructive surgical techniques. Two reviews included non-randomised studies (range 28-232 studies), three reviews included randomised trials (range 11-170 trials), and the last was a review of 33 systematic reviews.
Qualitative methods, including patient and healthcare professional interviews, were used by two core outcome sets to identify potential core outcomes to be entered into a formal consensus method (Table S3) . These methods, including data collection and analysis, were not described clearly within study reports.
All included core outcome sets used the modified Delphi method to identify core outcomes (Table S3) . 41 Participants included healthcare professionals (range 103-242 participants) and patients (range 24-154 participants). Individual stakeholder groups were clearly stated by a single core outcome set. 37 Two core outcome sets recruited participants from a single country (UK) and the remaining core outcome sets recruited participants from multiple countries (range 25-27 countries). The attrition rate varied between 21% and 48%. In addition, three core outcome sets arranged specific meetings to inform their development. Participants included healthcare professionals (range 13-25 participants), researchers (range 1-10 participants), and patients (range 2-15 participants). No core outcome set described a formal consensus method, but rather came to consensus through semi-structured discussion and voting.
No core outcome set fulfilled the COS-STAR statement's reporting criteria (Table S4) . Eight of the 18 criteria (17); and conflicts of interest (18) .
Discussion

Main findings
Forty-nine core outcome sets relevant to women's and newborn health have been registered, the majority in the last 2 years. Although a wide range of outcome sets are in development, several areas are currently under-represented, including benign gynaecology and newborn health. The quantitative, qualitative, and consensus methods used by core outcome set developers have varied considerably, and only a minority have published a protocol. Four core outcome sets have been completed to date, including reconstructive breast surgery, preterm birth, epilepsy in pregnancy, and maternity care. All have used the modified Delphi method to identify core outcomes engaging with stakeholders, including patients. The number of core outcomes included in the final core outcome set varies considerably from 11 to 48. No core outcome sets have determined how or when core outcomes should be measured.
Strengths and limitations
To our knowledge, this is the first systematic review to characterise and evaluate registered, ongoing, and published core outcome sets relevant to women's and newborn health. The strengths of this systematic review include its comprehensive search strategy and design ensuring the review process and data extraction were conducted independently by two authors. This empirical evaluation is not without limitations. The search strategy was limited to the COMET initiative and CROWN initiative databases. Additional core outcome sets could have been identified by expanding the search to other bibliographical databases, for example, the Cochrane Methodology Register. However, identifying core outcome sets is challenging, as no appropriate medical subject heading exists and prospective registration is not compulsory. 42 A limited number of registered core outcome sets have published a protocol, thus accurately assessing their methods and progress is challenging. There are no established criteria to assess the quality of completed outcome sets. Therefore, no decisions about quality of developed core outcome sets and subsequent recommendations for their adoption can confidently be made.
Interpretation
Although prospective registration is not currently mandated for core outcome sets, its implementation could help prevent unnecessary duplication of research effort, assist key stakeholders to identify planned or ongoing core outcome sets, and ensure approval and design of new research studies is informed by relevant core outcome sets. 43 Publishing core outcome set protocols could provide an additional strategy to improve core outcome set research in a similar fashion as prospective registration. Researchers would be able to obtain feedback on draft core outcome set protocols through peer review and enable consumers to compare what was originally intended with what was actually done. 44 There is currently limited guidance for the most appropriate methods to develop core outcome sets. This systematic review has identified significant variation in the quantitative, qualitative, and consensus methods used. 2, 45 For example, researchers have designed their modified Delphi technique using different strategies, perhaps recruiting participants from a single country or combining different stakeholders into a single group, decisions that are rarely justified. 11, [37] [38] [39] The number of core outcomes included in the final core outcome set varies considerably from 11 to 48. The high number of core outcomes recommended in several sets, may limit their implementation and encourage researchers to continue to 'cherry pick' the outcomes collected and reported. Given the uncertainty in core outcome set development methods, further methodological research is urgently required to standardise the approach. 2 There is significant core outcome set development in women's and newborn health and embedding methodological research within the development of individual sets should be encouraged. An instrument for assessing the methodological quality of core outcome sets is currently in development which should facilitate objective assessment to support recommendations regarding dissemination and implementation. 8 No core outcome set included in this systematic review has associated core outcomes with specific measures. Determining how core outcomes should be measured is necessary to limit unwarranted variation. Associating core outcomes with outcome measures is challenging and requires significant methodological expertise. 46 There are several frameworks to identify and assess potential outcome measurement instruments. 46, 47 For example, the Outcome Measures in Rheumatology (OMERACT) initiative has designed an explicit framework comprising truth, discrimination, and feasibility to assess the quality of potential outcome measures. 44 Without standardised outcome measures it is difficult to envisage a situation where core outcome sets will be robustly implemented within clinical studies.
Effective dissemination and implementation of core outcome sets will be required to eliminate the unwarranted and confusing variation in outcomes and outcome measures. Reporting research is as important a part of a core outcome set study as its design or analysis. A reporting guideline for core outcome sets, the COS-STAR Statement, has recently been published. 10 Speciality journals participating within the CROWN initiative have committed to implementing the COS-STAR statement to ensure the methods are described unambiguously and the results clear. 5 In the last two years, the number of core outcome sets in development has risen exponentially. The development of infrastructure to evaluate, disseminate, and implement core outcome sets within women's and newborn health is urgently required to ensure effective and timely dissemination and implementation.
Conclusions
Core outcome sets are currently being developed across women's and newborn health, although several areas are currently under-represented, including benign gynaecology and newborn health. Key stakeholders, for example, healthcare professionals, researchers and patients, could be encouraged to participate in their development. We recommend core outcome researchers should: prospectively register, develop and publish a robust protocol, engage in methodological research, and follow reporting guidelines. The development of infrastructure to develop, disseminate, and implement core outcome sets is urgently required.
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